Formulation development and optimization of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate (TDF) 300 mg FDC tablets by D-optimal mixture design

The usage of fixed dose combination (FDC) tablets of Lamivudine and Tenofovir Disoproxil Fumarate (TDF) is increasing due to increased incidences of HIV/Hepatitis B and HIV/TB co-infections. This is likely to increase the financial crisis due to limited resources for funding procurement of ready-mad...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Heliyon
Main Authors: Tibalinda, Prosper, Sempombe, Joseph, Shedafa, Raphael, Masota, Nelson, Pius, Dickson, Temu, Mary, Kaale, Eliangiringa
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5137174/
https://ncbi.nlm.nih.gov/pubmed/27942608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2016.e00207
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki